MEMORY PHARMACEUTICALS CORP·4

Apr 12, 4:47 PM ET

HOFFMANN LA ROCHE INC 4

4 · MEMORY PHARMACEUTICALS CORP · Filed Apr 12, 2004

Insider Transaction Report

Form 4
Period: 2004-04-08
Transactions
  • Conversion

    Series R Convertible Preferred Shares

    2004-04-082,777,7780 total
    Common Stock (925,926 underlying)
  • Conversion

    Common Stock

    2004-04-08+925,926925,926 total
Footnotes (3)
  • [F1]Each share of Convertible Preferred Stock converted into .3333 shares of Common Stock.
  • [F2]These securities automatically converted into Common Stock upon the closing of the Issuer's intitial public offering.
  • [F3]These securities do not have an expiration date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION